Lataa...
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors
The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. Despite adequate first-line treatment, nearly one third of patients relapse and almost half develop cisplatin-resistant disease, which is often fatal. The treatment of cisplatin-resistant dis...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2019-10-01
|
| Sarja: | Cancers |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2072-6694/11/10/1584 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|